NYSE:WAT - Waters Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
$185.67 -2.67 (-1.42 %)
(As of 08/15/2018 02:07 PM ET)
Previous Close$187.25
Today's Range$184.81 - $187.26
52-Week Range$177.58 - $220.20
Volume12,480 shs
Average Volume558,574 shs
Market Capitalization$14.64 billion
P/E Ratio24.92
Dividend YieldN/A
Beta0.98
Waters logoWaters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. The company also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. In addition, the company offers thermal analysis, rheometry, and calorimetry instruments, which are used in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for use in various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNYSE:WAT
CUSIP94184810
Phone508-478-2000

Debt

Debt-to-Equity Ratio0.58
Current Ratio6.58
Quick Ratio5.95

Price-To-Earnings

Trailing P/E Ratio24.92
Forward P/E Ratio22.87
P/E Growth2.33

Sales & Book Value

Annual Sales$2.31 billion
Price / Sales6.20
Cash Flow$8.7210 per share
Price / Cash21.29
Book Value$28.09 per share
Price / Book6.61

Profitability

EPS (Most Recent Fiscal Year)$7.49
Net Income$20.31 million
Net Margins2.12%
Return on Equity27.85%
Return on Assets13.03%

Miscellaneous

Employees7,000
Outstanding Shares77,070,000
Market Cap$14.64 billion

Waters (NYSE:WAT) Frequently Asked Questions

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How will Waters' stock buyback program work?

Waters declared that its board has authorized a stock repurchase plan on Tuesday, April 24th 2018, which permits the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 18.2% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) released its quarterly earnings results on Tuesday, July, 24th. The medical instruments supplier reported $1.95 EPS for the quarter, beating the Zacks' consensus estimate of $1.92 by $0.03. The medical instruments supplier had revenue of $596.20 million for the quarter, compared to analyst estimates of $598.73 million. Waters had a net margin of 2.12% and a return on equity of 27.85%. The business's revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.76 earnings per share. View Waters' Earnings History.

When is Waters' next earnings date?

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, October, 23rd 2018. View Earnings Estimates for Waters.

What guidance has Waters issued on next quarter's earnings?

Waters updated its FY18 earnings guidance on Tuesday, July, 24th. The company provided earnings per share (EPS) guidance of $8.05-8.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.18. Waters also updated its Q3 guidance to $1.85-1.95 EPS.

What price target have analysts set for WAT?

16 brokers have issued 12-month target prices for Waters' shares. Their forecasts range from $180.00 to $230.00. On average, they expect Waters' share price to reach $205.50 in the next twelve months. This suggests a possible upside of 10.5% from the stock's current price. View Analyst Price Targets for Waters.

What is the consensus analysts' recommendation for Waters?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 2 sell ratings, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters.

Who are some of Waters' key competitors?

Who are Waters' key executives?

Waters' management team includes the folowing people:
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 51)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 54)
  • Dr. Michael C. Harrington, Sr. VP of Global Markets (Age 57)
  • Mr. Ian S. King, Sr. VP of Global Products (Age 61)
  • Mr. Eugene G. Cassis, Sr. Advisor (Age 61)

Has Waters been receiving favorable news coverage?

Press coverage about WAT stock has trended somewhat positive on Wednesday, Accern reports. The research group identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Waters earned a daily sentiment score of 0.04 on Accern's scale. They also assigned news articles about the medical instruments supplier an impact score of 47.43 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for Waters.

Who are Waters' major shareholders?

Waters' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.30%), Massachusetts Financial Services Co. MA (6.09%), Bank of New York Mellon Corp (5.56%), Baillie Gifford & Co. (3.26%), Janus Henderson Group PLC (2.67%) and Veritas Asset Management LLP (2.17%). Company insiders that own Waters stock include Arthur G Caputo, Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

Which major investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Morgan Stanley, Veritas Asset Management LLP, Massachusetts Financial Services Co. MA, Renaissance Technologies LLC, American Century Companies Inc., Millennium Management LLC and Russell Investments Group Ltd.. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Insider Buying and Selling for Waters.

Which major investors are buying Waters stock?

WAT stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Schwab Charles Investment Management Inc., Wells Fargo & Company MN, Assenagon Asset Management S.A., Select Equity Group L.P., Mawer Investment Management Ltd., Canada Pension Plan Investment Board and Pinebridge Investments L.P.. View Insider Buying and Selling for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $185.97.

How big of a company is Waters?

Waters has a market capitalization of $14.64 billion and generates $2.31 billion in revenue each year. The medical instruments supplier earns $20.31 million in net income (profit) each year or $7.49 on an earnings per share basis. Waters employs 7,000 workers across the globe.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (NYSE WAT)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  328 (Vote Outperform)
Underperform Votes:  428 (Vote Underperform)
Total Votes:  756
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.